These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16932267)

  • 21. [Determination of apolipoproteins: An important tool for prevention and treatment of cardiovascular diseases].
    Wiklund O
    Lakartidningen; 2007 May 14-29; 104(20-21):1623-4. PubMed ID: 17564272
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative studies of the blood lipids and apolipoproteins A1 and B in patients underwent coronary artery bypass grafting under on-pump and off-pump bypass].
    Mei YQ; Lu YF; Tang CZ; Wu MY; Hu DY
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1997-9. PubMed ID: 17064600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk markers in adolescent girls with anorexia nervosa.
    Arisaka O; Ichikawa G; Yamazaki Y; Shimura N
    J Pediatr; 2007 Oct; 151(4):e16; author reply e16. PubMed ID: 17889059
    [No Abstract]   [Full Text] [Related]  

  • 24. Meet LDL's partner in plaque. ApoB puts the "bad" in bad cholesterol.
    Gebel E
    Diabetes Forecast; 2008 May; 61(5):39-40. PubMed ID: 18499924
    [No Abstract]   [Full Text] [Related]  

  • 25. Strategies for optimizing lipid management.
    Ballantyne CM
    Postgrad Med; 2004 Sep; 116(3 Suppl):13-20. PubMed ID: 19667671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of a dietary portfolio diet of cholesterol-lowering foods and a statin on LDL particle size phenotype in hypercholesterolaemic participants.
    Gigleux I; Jenkins DJ; Kendall CW; Marchie A; Faulkner DA; Wong JM; de Souza R; Emam A; Parker TL; Trautwein EA; Lapsley KG; Connelly PW; Lamarche B
    Br J Nutr; 2007 Dec; 98(6):1229-36. PubMed ID: 17663803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-density lipoprotein cholesterol reduction: the end is more important than the means.
    LaRosa JC
    Am J Cardiol; 2007 Jul; 100(2):240-2. PubMed ID: 17631077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I--new risk factors and targets for therapy.
    Walldius G; Jungner I
    Nutr Metab Cardiovasc Dis; 2007 Oct; 17(8):565-71. PubMed ID: 17631989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
    Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW
    Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LDL species heterogeneity in the atherogenic dyslipidemia of polycystic ovary syndrome.
    Doi SA; Abbas JM; Parkinson L; Chakraborty J; Akanji AO
    Am J Clin Pathol; 2008 May; 129(5):802-10. PubMed ID: 18426742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menopause, increased iron stores and cholesterol.
    Mascitelli L; Pezzetta F; Goldstein MR
    Maturitas; 2010 Apr; 65(4):403. PubMed ID: 20129745
    [No Abstract]   [Full Text] [Related]  

  • 32. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides].
    Posadas-Romero C; Posadas-Sánchez R; Juárez-Rojas JG; Medina-Urrutia A; Jorge-Galarza E; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Peŕez E
    Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B.
    Kastelein JJ; Wedel MK; Baker BF; Su J; Bradley JD; Yu RZ; Chuang E; Graham MJ; Crooke RM
    Circulation; 2006 Oct; 114(16):1729-35. PubMed ID: 17030687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis.
    Vaverkova H; Karasek D; Novotny D; Jackuliakova D; Lukes J; Halenka M; Frohlich J
    Clin Biochem; 2009 Aug; 42(12):1246-51. PubMed ID: 19450572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small, dense low-density-lipoproteins and the metabolic syndrome.
    Rizzo M; Berneis K
    Diabetes Metab Res Rev; 2007 Jan; 23(1):14-20. PubMed ID: 17080469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
    Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
    J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-density lipoprotein (LDL) particle size in healthy prepubertal children: the STRIP study.
    Kaitosaari T; Rönnemaa T; Viikari J; Leino A; Jokinen E; Simell O
    Acta Paediatr; 2006 Dec; 95(12):1668-73. PubMed ID: 17129981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [LDL abnormalities and arteriosclerosis].
    Kume N
    Nihon Naika Gakkai Zasshi; 2001 Oct; 90(10):1967-74. PubMed ID: 11769486
    [No Abstract]   [Full Text] [Related]  

  • 40. [LDL cholesterol in cardiovascular risk patients should be as low as possible].
    MMW Fortschr Med; 2007 Oct; 149(41):44-5. PubMed ID: 17992793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.